Australia Updates Gestational Diabetes Screening Guidelines to Focus Care on Those Most at Risk

Australia is set to implement new national guidelines for screening pregnant women for gestational diabetes, marking the first major update to testing protocols in more than a decade. The changes, released by the Australasian Diabetes in Pregnancy Society and published in the Medical Journal of Australia, are expected to affect over 280,000 pregnant women annually.

What is Gestational Diabetes?

Gestational diabetes is a condition characterized by high blood sugar levels that are first detected during pregnancy. While most cases resolve after childbirth, women diagnosed with gestational diabetes are at least seven times more likely to develop type 2 diabetes later in life. Routine screening remains recommended for all pregnant women in Australia to reduce risks such as large birth size (macrosomia), difficult deliveries, cesarean sections, and pre-eclampsia—a serious condition involving high blood pressure and protein in the urine.

Why Are Testing Guidelines Changing?

The new guidelines aim to reduce unnecessary diagnoses among women at lower risk, thereby decreasing the burden of extra monitoring and interventions. This shift will allow health services to focus care and support on women and babies who will benefit most. The update also seeks to address negative impacts of overdiagnosis, such as stigma, restricted dieting without supervision, and changes to maternity care providers or birth locations.

Key Changes in Screening

• Universal Screening Continues: All pregnant women without a prior diagnosis of diabetes will still be screened between 24 and 28 weeks of pregnancy using the oral glucose tolerance test (OGTT).

• Targeted Early Testing: Women with risk factors—such as a higher body mass index (BMI), a previous large baby, or a history of gestational diabetes—will receive early screening in the first trimester, often with a non-fasting HbA1c blood test.

• Higher Diagnostic Thresholds: Women will only be diagnosed with gestational diabetes if their blood glucose levels exceed new, higher cut-off points on the OGTT, both early and later in pregnancy.

• Reduced Repeated Testing: Fewer women will undergo the OGTT more than once during pregnancy, reserving early testing for those with specific risk factors.

What This Means for Pregnant Women

These changes are designed to ensure that resources are focused on those who need them most, supporting healthier pregnancies and better outcomes for mothers and babies. Women are encouraged to discuss the new guidelines with their maternity care providers to understand how the changes may affect their care.

Disclaimer

The information in this article is based on current guidelines and expert commentary as of June 2025. It is intended for general informational purposes only and does not replace professional medical advice. Pregnant women should consult their healthcare providers for personalized recommendations and care.